£233k
−11%vs Sept 2024ActiveSC288225Private limited companyEdinburgh
ONCOBIOPHARM LIMITED
Significant control: Christopher Barry Wood (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Oncobiopharm Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Oncobiopharm Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
ONCOBIOPHARM LIMITED is an active private limited company (company number SC288225) incorporated on 29 July 2005, registered in Edinburgh. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 30 September 2025, showing net assets of £233k and cash of £4,832, with 4 employees on average. Net assets fell 11% on the prior period (£261k).
Peer position · net assets
By net assets it sits in the top quarter of 62 comparable companies in Edinburgh (median £4,168, upper quartile £51k).
02
Ownership and control
- Mr Christopher Barry Wood
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 29 July 200521 yrs ago
- Next accounts due
- 30 June 2027in 249 days
- Confirmation statement due
- 12 August 2027in 292 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£4,832
+9%vs Sept 2024Not reported
4
−20%vs Sept 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 September 2025 | £233k | £4,832 | £137k | £78k | — | — | 4 |
| 30 September 2024 | £261k | £4,449 | £139k | £62k | — | — | 5 |
Current ratio1.81Current assets ÷ creditors within one year
Cash per employee£1,208Cash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £232,642 at 30 September 2025
- Current assets at least 1.5× creditors within one yearCurrent ratio 1.81
- Incorporated five or more years agoIncorporated 29 July 2005
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 292 days
- Next accounts duein 249 days
- Accounts period endNet assets £233k · small accounts
- Accounts period endNet assets £261k · small accounts
- Incorporated
08
Similar companies in Edinburgh
- INTELLIPOWER GROUP PLCEast Saltoun · inc. Oct 2005
- ETIVE GEOCONSULTING LIMITEDEdinburgh · inc. Apr 2007
- FIOS GENOMICS LIMITEDEdinburgh · inc. Apr 2008
- CENSO BIOTECHNOLOGIES LTDMidlothian · inc. Sept 2008
- MGB BIOPHARMA LIMITEDEdinburgh · inc. Jul 2009
- EDIXOMED LIMITEDEdinburgh · inc. Jul 2009
All companies incorporated on 29 July 2005 · in Jul 2005.
09
Reminders for ONCOBIOPHARM LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.